Effect [qlco]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
Stroke [dsyn]
postmenopausal [tmco]
Women [popg]
Initiative [menp]
randomized [resa]
Trial [resa]
Context [fndg]
Initiative [menp]
WHI [inpr]
Trial [resa]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
stopped [qlco]
Early [tmco]
adverse effects [ftcn]
Including [ftcn]
Increased [qnco]
Risk [qlco]
Stroke [dsyn]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
Group [idcn]
Objective [inpr]
Assess [acty]
Effect [qlco]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
Ischaemic [ftcn]
Haemorrhagic stroke [patf]
subgroups [virs]
To [qlco]
Effect [qlco]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
Modified [ftcn]
baseline [bodm]
Level [qlco]
Blood [tisu]
Biomarkers [clna]
Design [acty]
Trial, Multicenter [resa]
DOUBLE BLIND [resa]
placebo-controlled [resa]
randomized [resa]
Clinical [qlco]
Involving [ftcn]
Women [popg]
Aged [orga]
Average [qnco]
Follow-up [fndg]
baseline [bodm]
Level [qlco]
Blood [tisu]
Based [ftcn]
Marker [clna]
Inflammation [patf]
Thrombosis [patf]
Lipid level [lbtr]
Measured [qlco]
First [qnco]
confirmed [qlco]
Stroke [dsyn]
Cases [ftcn]
Control [grup]
interventions [hlca]
participants [popg]
Received [qlco]
mg/d [qnco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
mg/d [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
N NOS [aapp, imft]
placebo [topp]
N NOS [aapp, imft]
Main [qlco]
Outcome [ftcn]
Measure [qnco]
Overall [inpr]
Strokes [dsyn]
Stroke [dsyn]
Subtype [clas]
Severity [qlco]
Stroke [dsyn]
neurologists [prog]
Result [ftcn]
One [qnco]
Patients [podg]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
placebo [topp]
Group [idcn]
Strokes [dsyn]
Overall [inpr]
Strokes [dsyn]
Ischaemic [ftcn]
Combined [qlco]
Ischaemic [ftcn]
Haemorrhagic stroke [patf]
Intention [menp]
TREAT [ftcn]
Hazard Ratio [qnco]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
placebo [topp]
Confidence Interval [qnco]
Adjustment [inbe]
Adherence [ftcn]
Hazard Ratio [qnco]
Confidence Interval [qnco]
Hazard Ratio [qnco]
Ischaemic stroke [dsyn]
Confidence Interval [qnco]
Haemorrhagic stroke [patf]
Confidence Interval [qnco]
Point [qnco]
Estimate [qnco]
Excess [qlco]
Risk [qlco]
Stroke [dsyn]
apparent [idcn]
Age Groups [aggp]
Categories [inpr]
baseline [bodm]
Stroke risk [inpr]
Women [popg]
Hypertension [dsyn]
Prior [tmco]
History [ocdi]
Cardiovascular disease [dsyn]
Hormones [horm]
Statins [orch, phsu]
Aspirin [orch, phsu]
risk factors [qnco]
Stroke [dsyn]
Including [ftcn]
Smoking [inbe]
Blood Pressure [orgf]
Diabetes [dsyn]
Lower [spco]
Vitamin C supplement [food]
Blood [tisu]
Based [ftcn]
Biomarkers [clna]
Inflammation [patf]
high white blood cell count [fndg]
high haematocrit [fndg]
Levels [qlco]
Not [ftcn]
MODIFY [ftcn]
Effect [qlco]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
Stroke risk [inpr]
Conclusions [idcn]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
Increase [ftcn]
Risk [qlco]
Ischaemic stroke [dsyn]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Excess [qlco]
Risk [qlco]
Strokes [dsyn]
Attribute [idcn]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
APPEAR [qlco]
To [qlco]
Present [qnco]
subgroups [virs]
Women [popg]
Examined [fndg]
